ASN95 -- Selected abstracts: Vascular Access

Sun. Nov. 5 1995

9:30 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Hemodialysis access

Program number 179 Board# S179 at 10:45 A.M.
* The multinational study of dialysis therapy: Hemodialysis access. A.J. Bleyer, A.P. Disney, B. Hylander, Y. Nomoto, P.T.H. Coates, E. De la Torre, A. Bjorklund and J.M. Burkart. - Winston-Salem, NC; Adelaide, Australia; Stockholm, Sweden and Isehara City, Japan.

Program number 180 Board# S180 at 10:45 A.M.
* The impact of platelet activation in hemodialysis patients. D. Kikeri, U. Marzec, B. Noe, M.J. MacDonald, P.A. McManus, A.B.Lumsden, J.F. Neylan and L.A. Harker. - Atlanta, GA.

Program number 181 Board# S181 at 10:45 A.M.
* In vitro permanent catheter assessment and evaluation for high efficiency hemodialysis. G.J. Mishkin, S.Q. Lew, V. Barlee, B. Von Albertini and J.P. Bosch. - Washington, DC.

Program number 182 Board# S182 at 10:45 A.M.
* Vascular access survival in hemodialysis patients. M.N. Turenne, R.L. Strawderman, J.D. Woods, R.A. Hirth, E. Young, J.C. Hornberger, L.Y.C. Agodoa and P.J. Held. - Ann Arbor, MI.

Program number 183 Board# S183 at 10:45 A.M.
* Effect of hemodialysis access on delivered dose of dialysis (Kt/V). K.M. Erbeck, M.E. Brier, P. DeOreo, R.J. Hamburger and R.A. Ward. - Louisville, KY.

Program number 185 Board# S185 at 10:45 A.M.
* New surface treated catheters for blood access for extracorporeal detoxification methods. R. Bambauer, P. Mestres, R. Schiel and P. Sioshansi. - Homburg, Germany and Bedford, MA.

Program number 186 Board# S186 at 10:45 A.M.
* Access blood flow measurements in the low flow range by an ultrasonic device are accurate. F.T.J. Boereboom, P.J. Bosman, P.J. Blankestijn and H.A. Koomans. - Utrecht, The Netherlands.

Program number 187 Board# S187 at 10:45 A.M.
* Access recirculation by ultrasonic dilution compared to a 20 sec slow flow urea method. T.O. George, A. Priester-Coary, G. Dunea and J.T. Daugirdas. - Chicago, IL.

Program number 188 Board# S188 at 10:45 A.M.
* Blood recirculation in central temporary catheters for acute hemodialysis. M. Leblanc, S. Fedak, G. Mokris and E.P. Paganini. - Cleveland, OH.

Program number 190 Board# S190 at 10:45 A.M.
* Effects of antiplatelet drugs on dialysis-associated platelet deposition in PTFE grafts. D.W. Windus, S.A. Santoro and H.Royal. - St. Louis, MO.

Program number 191 Board# S191 at 10:45 A.M.
* Extracorporeal venous drip chamber pressure measurement screening does not predict impending hemodialysis access graft failure. V.A. Lavarias, A.M. Kaufman, M.I. Levine and N.W. Levin. - New York, NY.

Program number 192 Board# S192 at 10:45 A.M.
* The relation of brachial artery flow to access flow. A. Besarab, B. Hall, F. El-Ajel, C. Deane and G. Zasuwa. - Detroit, MI and Philadelphia, PA.

Program number 193 Board# S193 at 10:45 A.M.
* Do patients with angiographically proven access stenosis have low access blood flow? F.T.J. Boereboom, P.J. Bosman, P.J. Blankestijn and H.A.Koomans. - Utrecht, The Netherlands.

Program number 194 Board# S194 at 10:45 A.M.
* Hemodialysis vascular access practice patterns. R.A. Hirth, M.N. Turenne, J.D. Woods, E.W. Young, J.W. Greer, M.V. Pauly and P.J. Held. - Ann Arbor, MI.

Program number 195 Board# S195 at 10:45 A.M.
* The efficacy and complications of aspirin versus heparin in postoperative prophylaxis against thrombosis in newly placed hemodialysis access. G.B. Zibari, M.F. Gadallah, M.D. Landreneau, R. McMillan, R. Bridges, K. Costley, J. Work and J.C. McDonald. - Shreveport, LA.

Program number 196 Board# S196 at 10:45 A.M.
* The relation of recirculation to access flow. A. Besarab, R. Ross, A. Effendi and S. Frinak. - Detroit, MI and Philadelphia, PA.

Program number 197 Board# S197 at 10:45 A.M.
* A new, Fick-principle based, method for measuring blood flow in hemodialysis grafts validated by magnetic resonance angiography. P.J. Bosman, F.T.J. Boereboom, C.J. Bakker, W.P.T.M. Mali, B.C. Eikelboom, P.J. Blankestijn and H.A.Koomans. - Utrecht, The Netherlands.

Program number 198 Board# S198 at 10:45 A.M.
* Access flow measured from recirculation of urea during hemodialysis with reversed blood lines. T.A. Depner and N.M. Krivitski. - Davis, Ca and Ithaca, NY.

Program number 199 Board# S199 at 10:45 A.M.
* Inaccuracy of urea method to calculate dialysis access recirculation. R.J. Kossmann and S. Ahmad. - Seattle, WA.

Program number 200 Board# S200 at 10:45 A.M.
* Percutaneous creation of arteriovenous hemodialysis grafts: Work in progress. S.O. Trerotola, W.M. Johnson, T. Winkler and R.G. Dreesen.- Indianapolis, IN.

Program number 201 Board# S201 at 10:45 A.M.
* Quantitative and histological analysis of clotted hemodialysis access grafts. S.O. Trerotola, T. Winkler, D. Davidson and M. Milgrom. - Indianapolis, IN.

Program number 202 Board# S202 at 10:45 A.M.
* Silastic twin catheters for hemodialysis (twincath): 13 years experience. B. Canaud, H. Leray, C. Vela, K. Klouche, J.J. Beraud and C. Mion. - Montpellier, France.

Program number 203 Board# S203 at 10:45 A.M.
* Hemodialysis central venous catheters: Looking for optimal blood flow. G. Jean, C. Chazot, T. Vanel, B. Charra, J.C. Terrat, E. Calemard and G.Laurent. - Tassin, France.

Program number 204 Board# S204 at 10:45 A.M.
* Dermatan sulphate to prevent clotting of the extracorporeal circuit in hemodialysis patients. S. Rota, G. Vigano, A. Remuzzi and G. Mecca. - Bergamo, Italy.

Program number 205 Board# S205 at 10:45 A.M.
* Increasing AV fistulas for hemodialysis access. J.J. Sands and C.L. Miranda. - Wilkes-Barre, PA.

Program number 206 Board# S206 at 10:45 A.M.
* Measurement of access flow by thermodilution: in vitro experiments. D. Schneditz, K. Martin and N.W. Levin. - Graz, Austria and New York, NY.

Program number 207 Board# S207 at 10:45 A.M.
* Mutation at Arg506 of coagulation factor V and access thrombosis in hemodialysis patients. G. Sunder-Plassmann, M. Fodinger, C. Mannhalter and W.H. Horl. - Vienna, Austria.

Program number 220 Board# S220 at 10:45 A.M.
* Safety of hemodialysis machines: Surveillance of the venous blood return. F. Dellanna, D. Stippel, W. Schmitz and C.A. Baldamus. - Cologne, Germany.

Program number 224 Board# S224 at 10:45 A.M.
* Urea recirculation measured by the two- and three-site methods compared with Doppler ultrasound. M.F. Gadallah, W.D. Paulson, C. Birk and J. Work. - Shreveport, LA.

9:30 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Modeling in dialysis: Techniques and applications I

Program number 245 Board# S245 at 10:45 A.M.
* Screening for extreme postdialysis urea rebound using the smye method. J.T. Daugirdas, P. Balter, M.S. Burke, A. Priester-Coary and T. Majka.- Chicago and Oak Park, IL.

Mon. Nov. 6 1995

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Complications and outcomes in end-stage renal disease I

Program number 869 Board# M138 at 10:00 A.M.
* Activated protein C resistance in patients on hemodialysis. B.S. Hoch, I.U. Nawabi, M. Cicero, S.J. Shahmehdi, B.M. Louis, C. Hernandez, N. Namboodiri, G. Neiderman, S. Borra and H.I. Lipner. - Brooklyn, NY.

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Modeling in dialysis: Techniques and applications II

Program number 1016 Board# M285 at 10:00 A.M.
* Effect of access recirculation on the modeled urea distribution volume. J.T. Daugirdas, D. Schneditz and D.J. Leehey. - Chicago and Maywood, IL and Graz, Austria.

4:00 P.M. ---Free Communications--- San Diego Conv Ctr Rm 5ab
Access for and methods of dialysis I

Program number 1357 at 4:00
* The relation of intra-access pressure to intra-access flow. A. Besarab, R. Ross, F. El-Ajel, C. Deane, S. Frinak and G. Zasuwa. - Detroit, MI and Philadelphia, PA.

Program number 1358 at 4:15
* Simplified accurate measurement of access recirculation with an in-line hematocrit device. M. Germain, R. Steuer, D. Miller, J. Mulhern, M. O'Shea and G. Braden. - Springfield and Boston, MA and Riverdale, UT.

Tue. Nov. 7 1995

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Complications and outcomes in end-stage renal disease III

Program number 1612 Board# T162 at 10:00 A.M.
* Preoperative vancomycin prophylaxis decreases the incidence of hemodialysis vascular access infections. G.B. Zibari, M.F. Gadallah, M.D. Landreneau, R. McMillan, R. Bridges, K. Costley, J. Work and J.C. McDonald. - Shreveport, LA.

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Access methods of peritoneal dialysis

Program number 1615 Board# T165 at 10:00 A.M.
* Bacterial spread from catheter exit site is reduced by silver catheter. M.K. Dasgupta. - Edmonton, Canada.

Program number 1620 Board# T170 at 10:00 A.M.
* Access-related infection in HIV sero positive dialysis patients: comparison of hemodialysis to peritoneal dialysis. J.A. Vassalotti, M.Choi, A. Whelton, W. Briggs, L. Gimenez and P.J. Scheel. - Baltimore, MD.


Use BACK arrow on your browser (faster) or click here to go back to ASN95 main page

UP Click on ARROW for HDCN Home Page.